| Dr Bader Kfoury, MD | |
|
4630 Ambassador Caffery Pkwy, Ste 408, Lafayette, LA 70508-6950 | |
| (337) 470-3980 | |
| (337) 470-3989 |
| Full Name | Dr Bader Kfoury |
|---|---|
| Gender | Female |
| Speciality | Nephrology |
| Experience | 10 Years |
| Location | 4630 Ambassador Caffery Pkwy, Lafayette, Louisiana |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1518349919 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Our Lady Of Lourdes Regional Medical Center, Inc | Lafayette, LA | Hospital |
| Lafayette General Medical Center | Lafayette, LA | Hospital |
| Opelousas General Health System | Opelousas, LA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Lourdes Physician Group Llc | 7214177757 | 111 |
News Archive
Support for the development and application of this electronic nose comes from the National Institute of Environmental Health Sciences, part of the National Institutes of Health. The new technology is discussed in this month's issue of Nature Chemistry and exemplifies the types of sensors that are being developed as part of the NIH Genes, Environment and Health Initiative (GEI).
The Lancet Infectious Diseases' Newsdesk examines how resource gaps in immunizations, health workers and financing are creating barriers to efforts to achieve the U.N. Millennium Development Goal target to reduce child mortality by two-thirds by 2015, as highlighted in a recent Save the Children report.
VION PHARMACEUTICALS, INC. announced today that it had received a response from the U.S. Food and Drug Administration on a Special Protocol Assessment for its oncology therapeutic Onrigin™ (laromustine) Injection.
Early-life seizures are known to be associated with autism, and studies indicate that about 40 percent of patients with autism also have epilepsy. A study from Boston Children's Hospital finds a reason for the link, and suggests that an existing drug, already shown to be safe in children, could help prevent autism from developing in newborns who have seizures.
Stem cell research is making great strides. This is yet again illustrated by a study carried out by the I-STEM Institute (I-STEM/ Inserm UEVE U861/AFM), published in the Lancet on 21 November 2009. The I-STEM team, directed by Marc Peschanski has just succeeded in recreating a whole epidermis from human embryonic stem cells.
› Verified 2 days ago
| Entity Name | Lourdes Physician Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1437405883 PECOS PAC ID: 7214177757 Enrollment ID: O20130705000541 |
News Archive
Support for the development and application of this electronic nose comes from the National Institute of Environmental Health Sciences, part of the National Institutes of Health. The new technology is discussed in this month's issue of Nature Chemistry and exemplifies the types of sensors that are being developed as part of the NIH Genes, Environment and Health Initiative (GEI).
The Lancet Infectious Diseases' Newsdesk examines how resource gaps in immunizations, health workers and financing are creating barriers to efforts to achieve the U.N. Millennium Development Goal target to reduce child mortality by two-thirds by 2015, as highlighted in a recent Save the Children report.
VION PHARMACEUTICALS, INC. announced today that it had received a response from the U.S. Food and Drug Administration on a Special Protocol Assessment for its oncology therapeutic Onrigin™ (laromustine) Injection.
Early-life seizures are known to be associated with autism, and studies indicate that about 40 percent of patients with autism also have epilepsy. A study from Boston Children's Hospital finds a reason for the link, and suggests that an existing drug, already shown to be safe in children, could help prevent autism from developing in newborns who have seizures.
Stem cell research is making great strides. This is yet again illustrated by a study carried out by the I-STEM Institute (I-STEM/ Inserm UEVE U861/AFM), published in the Lancet on 21 November 2009. The I-STEM team, directed by Marc Peschanski has just succeeded in recreating a whole epidermis from human embryonic stem cells.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Bader Kfoury, MD 5959 S Sherwood Forest Blvd, Baton Rouge, LA 70816-6038 Ph: (225) 765-5727 | Dr Bader Kfoury, MD 4630 Ambassador Caffery Pkwy, Ste 408, Lafayette, LA 70508-6950 Ph: (337) 470-3980 |
News Archive
Support for the development and application of this electronic nose comes from the National Institute of Environmental Health Sciences, part of the National Institutes of Health. The new technology is discussed in this month's issue of Nature Chemistry and exemplifies the types of sensors that are being developed as part of the NIH Genes, Environment and Health Initiative (GEI).
The Lancet Infectious Diseases' Newsdesk examines how resource gaps in immunizations, health workers and financing are creating barriers to efforts to achieve the U.N. Millennium Development Goal target to reduce child mortality by two-thirds by 2015, as highlighted in a recent Save the Children report.
VION PHARMACEUTICALS, INC. announced today that it had received a response from the U.S. Food and Drug Administration on a Special Protocol Assessment for its oncology therapeutic Onrigin™ (laromustine) Injection.
Early-life seizures are known to be associated with autism, and studies indicate that about 40 percent of patients with autism also have epilepsy. A study from Boston Children's Hospital finds a reason for the link, and suggests that an existing drug, already shown to be safe in children, could help prevent autism from developing in newborns who have seizures.
Stem cell research is making great strides. This is yet again illustrated by a study carried out by the I-STEM Institute (I-STEM/ Inserm UEVE U861/AFM), published in the Lancet on 21 November 2009. The I-STEM team, directed by Marc Peschanski has just succeeded in recreating a whole epidermis from human embryonic stem cells.
› Verified 2 days ago
Dr. Maximo Bienvenido Lamarche, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 300 W Saint Mary Blvd, Lafayette, LA 70506 Phone: 337-233-6593 Fax: 337-235-1032 | |
Dr. John M Rainey, M.D. Nephrology Medicare: Medicare Enrolled Practice Location: 501 W Saint Mary Blvd, Lafayette, LA 70506 Phone: 337-235-7898 Fax: 337-235-7445 | |
Dr. Corwin Ashford Thomas, D.O. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 802 E Farrel Rd, Lafayette, LA 70508 Phone: 337-234-3163 Fax: 337-234-3168 | |
Dr. Matthew Shane Fontenot, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1214 Coolidge Blvd, Lafayette, LA 70503 Phone: 337-289-7927 Fax: 337-289-7935 | |
Dr. John Brent Rhodes Jr., M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 439 Heymann Blvd, Lafayette, LA 70503 Phone: 337-269-0963 Fax: 337-269-0553 | |
Leela P. Lakshmiprasad, MD Nephrology Medicare: Not Enrolled in Medicare Practice Location: Lsu Medicine Clinic, 2390 W Congress Street, Lafayette, LA 70506 Phone: 337-261-6100 | |
Dr. Kamalendra Nath Mondal, MD Nephrology Medicare: Medicare Enrolled Practice Location: 3149 Ambassador Caffery Pkwy, Lafayette, LA 70506 Phone: 337-706-3415 |